-
Recent Posts
- Demand for Mental Health Inpatient Beds in England (BBC News / NHS Strategy Unit)
- Dementia Services in England: Mega Statistical Package (PHE / NMHDNIN)
- Mandatory Learning Disability and Autism Awareness Training for NHS Staff (DHSC / BBC News)
- Detention of Children and Young People With Learning Disabilities and/or Autism (Joint Committee on Human Rights / BBC News)
- Building a Digital Ready Workforce: Digital Capabilities of Social Workers (SCIE / BASW)
Archives
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Department of Health and Social Care (DHSC)
- Health Education England (HEE)
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Employers
- NHS England
- NHS Evidence
- NHS Improvement
- NICE Guidelines
- NIHR
- NIHRSDO
- Northern Ireland
- Patients Association
- Public Health England
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Wales
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Google Translate (100+ Languages)
Tag Archives: Open Access Research
Challenges in Developing Disease-Modifying Treatments for Dementia (Department of Health)
Summary Raj Long, the Senior Regulatory Officer at the Bill & Melinda Gates Foundation, explores the problems in developing treatments for dementia. The independent “Finding a Path for the Cure for Dementia” report is a contribution to the G8 Dementia … Continue reading →
Posted in Charitable Bodies, Commissioning, Department of Health, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Models of Dementia Care, Patient Care Pathway, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest
|
Tagged Academia-Industry Partnerships, Academic Research, AIFA: Italian Medicines Agency, Attrition Analysis, BfArM: Federal Institute of Drugs and Medical Devices, BfArM: Federal Institute of Drugs and Medical Devices (Germany), Bill and Melinda Gates Foundation, Biopharmaceutical Companies, Burden of Dementia, Canada, CEOi: Global CEO Initiative on Alzheimer’s Disease, Challenge on Dementia (David Cameron), Charitable Funding, Clinical Trial Efficiencies, Collaboration, Collaborative Projects, Composite End Points, Consistent Global Development Pathways, Cross-Sector Partnerships, CTEG: Clinical and Technical Expert Group, Danish Health and Medicines Authority, Data Sharing, Dementia Challenge, Dementia Research, Dementia Research Funding, Dementia Research Priorities, Dementia Research: UK Impact, Denmark, Department of Health Dementia Challenge, Diagnosis and Referral, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DKMA: Danish Health and Medicines Authority, Drug Discovery Programmes, Drug Identification, Drug Regulation, Drug-Development Pipeline, Eli Lilly Inc., Eli Lilly’s UK Dementia Research Centre, EMA: European Medicines Agency, European Medicines Agency, European Union, FIH: First in Humans, Financial Incentives, First Global Ministerial Conference on Global Action Against Dementia, Food and Drug Administration, G20 Countries, G7 Countries, G8 Dementia Summit: Global Action Against Dementia, G8 Summit, Gaps in the Basic Science, Germany, Global Alzheimer’s and Dementia Action Alliance (GADAA), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Government Research Funding, Health Canada, IAP Steering Committee, IDAP Steering Committee, IDAP: International Dementia Advisory Platform, IFPMA: International Federation of Pharmaceutical Manufacturers & Associations, Incentives and Investment, Incentives for Drug Development, Independent Safety Review Committee, Integrated Development Pathway, International Collaborations, International Dementia Advisory Platform (IDAP), International Dementia Research Inventories, International Programmes, Italian Medicines Agency, Italy, Japan, Japan: Pharmaceuticals and Medical Devices (Japan), Knowledge Translation, MEB: Medicines Evaluations Board, Medicines and Healthcare Products Regulatory Agency, Medicines Evaluation Board Netherlands, MHRA: Medicines and Healthcare Products Regulatory Agency, Modelling and Extrapolation, Multilateral Cooperation, Multilateral Regulator Cooperation, Netherlands, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurological Research, OHE: Office of Health Economics, Open Access Databases, Open Access Knowledge Resources, Open Access Research, Open Science, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Co-operation and Development (OECD) Countries, Organisation for Economic Cooperation and Development, Partnership, Partnership and Collaboration, Partnership Working, Patient Viewpoint, Philanthropic Funding, Pipeline Databases, PMDA: Pharmaceutical and Medicines Devices Agency, Public-Private Partnership (PPP), Quantifiable Reproducible Outcome Measures, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Reasons for Termination of Trials, Regulator Perspectives, Regulatory Agencies, Regulatory Experts, Research and Developers’ Status Quo, Research and Development, Research and Innovation, Research Commitment, Research Funding, Research Status Quo, Resource and Incentives, Risk Benefit Balance, Standardisation and Validation of Cognitive Endpoints, Swiss Medic, Switzerland, United States, WDC: World Dementia Council, World Dementia Council, World Health Organisation (WHO)
|
Leave a comment
Prime Minister’s Challenge On Dementia 2020: £300m Government Funding Planned For Dementia Research (BBC News / Department of Health)
Summary In the wake of the three-year Prime Minister’s “Dementia Challenge” (2012), David Cameron has announced the follow-up Prime Minister’s Challenge On Dementia 2020. The plan is to further transform dementia research, dementia care and support. It is anticipated that … Continue reading →
Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, Antipsychotics, BBC News, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, End of Life Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Health Education England (HEE), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, NHS, NIHR, Non-Pharmacological Treatments, Patient Care Pathway, Patient Information, Person-Centred Care, Personalisation, Pharmacological Treatments, Public Health England, Quick Insights, Standards, Statistics, UK, Universal Interest, World Health Organization (WHO)
|
Tagged 5YFV: NHS Five Year Forward View, Academia-Industry Partnerships, Achieving Dementia Friendly Acute care, Age-Friendly Housing, Ageing and Dementia, Ageing and Society, Ageing Policy in the UK, Ageing Population, Alistair Burns: NHS England’s National Clinical Director for Dementia, Alzheimer's Association, Alzheimer’s Research UK (ARUK), Alzheimer’s Research UK Stem Cell Research Centre, Alzheimer’s Society Connecting Communities Project, Attributable Cost of Dementia, Awareness and Understanding, Awareness Campaigns, Barbara’s Story: Increasing Awareness of Dementia, Behavioural Risk Factors, Behavioural Risk Factors and Dementia, Better Care Fund, Black Asian and Minority Ethnic (BAME), Black Asian and Minority Ethnic Communities (UK), British Prime Minister's Office, Building Dementia Friendly Communities, Burden of Dementia, Butterfly Approach, Butterfly Scheme, Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) NHS Memory Clinic, Care and Compassion, Care at Home, Care Certificate, Carer Support, Carer Support Services, Challenge on Dementia (David Cameron), Citizen Participation, Collaboration, Collaborative Projects, Collaborative Research, Collaborative Working, Commitment to Carers (NHS England), Community Participation, Compassionate Care, Connecting Communities, Connecting Communities Initiative, Core Knowledge and Skills Framework, Crawley, Crawley Forward Thinking, Creating Dementia Friendly Environments, Creating Dementia Friendly Hospitals, Cross-Sector Partnerships, David Cameron, Dementia Action Alliance (DAA), Dementia Advisers, Dementia Advisor, Dementia Advisor Service, Dementia Awareness, Dementia Awareness Training, Dementia Challenge, Dementia Consortium, Dementia Friendly Charters, Dementia Friendly Communities Recognition Process: Crawley, Dementia Friends, Dementia Friends Campaign, Dementia Friends Champions, Dementia Friends Programme, Dementia Health and Care Champion Group, Dementia Research, Dementia Risk Factors, Dementia State of the Nation, Dementia Voice, Dementia-Friendly Businesses, Dementia-Friendly Care Homes, Dementia-Friendly Cities, Dementia-Friendly Communities, Dementia-Friendly Employers, Dementia-Friendly Football Clubs, Dementia-Friendly Hospitals, Dementia-Friendly Housing, Dementia-Friendly Neighbourhoods, Dementia-Friendly Sectors, Dementia-Friendly Towns, Dementias Platform UK, Dementias Platform UK (DPUK), Dennis Gillings: Former World Dementia Envoy, Department of Health Dementia Challenge, Department of Health Dementia Challenge (2020), Dignity in Care, Dignity in Dementia, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Elderly Human Rights, End of Life Care, End of Life Care for People with Dementia, Engaging Businesses in Dementia Friends, EPAD: European Prevention of Alzheimer's Dementia Consortium, EU Joint Action on Dementia 2015-18, EU Joint Programme on Neurodegenerative Disease Research (JPND), European Joint Action on Dementia: ALCOVE, European Prevention of Alzheimer's Dementia Consortium (EPAD), Finance and Incentives, Five Year Forward View (NHS England), Focused Intervention Training and Support (FITS), Forget Me Not Club, Forget Me Not Initiative, Free Open Access Journals, G8 Dementia Summit: Global Action Against Dementia, GCTF: Global Clinical Trials Fund, Global Action Against Dementia, Global Burden of Dementia, Global Clinical Trials Fund (GCTF), Global Fund on Dementia, Global Leadership, Global Outlook, Global Social Investment for Dementia, Global Societal Economic Cost of Dementia, Gnosall Model for Dementia, Greenwich Advanced Dementia Service (GADS), Greenwich Carers Centre, Guy’s and St Thomas’ NHS Foundation Trust (GSTT), Harrogate and District NHS Foundation Trust, Health and Care of Older People, Health and Housing Memorandum of Understanding (MoU), Healthy Behaviours, Healthy Communities, Healthy Lifestyles, Hilary Evans: Charity Director of Alzheimer’s Research UK, Housing and Dementia, Improving Care for People with Dementia, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Independent Expert for the Human Rights of Older People, Innovation for an Ageing Population, Integrated Development Pathway, Integration of Health and Care, International Collaborations, International Dementia Research Institute, International Dementia Research Inventories, International Programmes, Involvement and Participation, Jewish Care, Join Dementia Research, Join Dementia Research: Recruitment Onto Dementia Studies, Joint Action on Dementia, Joint Programme on Neurodegenerative Disease Research (JPND), Knowledge and Skills Required for Case Management, Leyton Orient: Dementia-Friendly Football Club, Lifestyle Risk Factors, Local Dementia Action Alliances, Local Dementia Action Alliances in England, Local Government, Local Health and Care Economies, Local Health and Care Services, Local Health and Wellbeing Boards, Loneliness and Dementia, Loneliness and Social Isolation, Maintaining Independence, Marks and Spencer, Medical Research Council (MRC), Men in Sheds, Modifiable Risk Factors, National Dementia and Antipsychotic Prescribing Audit 2012, National Institute for Health Research (NIHR), NHS England's Five Year Forward View (2014), NHS England’s Commitment to Carers, NHS Five Year Forward View (5YFV), NHS Health Check, NHS Health Check Programme, NICE Quality Standards, NIHR Dementia Translational Research Collaboration, One Million NHS Staff Trained (Dementia Awareness), Open Access Databases, Open Access Journals, Open Access Knowledge Resources, Open Access Research, Open Science, Open Science and Data, Open Source Solutions, Organisation for Economic Co-operation and Development (OECD), Otto Schiff Care Home (Golders Green), Oxleas NHS Foundation Trust, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Partnership Working, Patient and Public Participation, PETALS (Person-Centred Empowerment Trust Activities Life History and Stimulation), Peterborough City Council, Pharmaceutical Industry, PM Challenge on Dementia: Health and Care Champion Group Subgroup on Dementia and Homecare, Prevalence of Dementia, Prime Minister's Challenge on Dementia, Prime Minister's Office, Prime Minister’s Challenge On Dementia 2020, Prime Minister’s Dementia Challenge, Prof; Simon Lovestone: Co-Lead Academic Scientists at Oxford Drug Discovery Institute, Professor Alistair Burns, Public Health England (PHE), Public Participation in Research, Public Sector, Public Sector Outcomes, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Stigma, Referrals, Research and Innovation, Resource and Incentives, Resources for Enhancing Alzheimer's Caregiver Health (REACH), Risk Factors, Risk Factors for Alzheimer's Diseease, Risk Management, Road Less Rocky, Rosa Kornfield-Matte: Independent Expert on Human Rights, Science and Innovation, Skills for Care, Somerset Care, South Manchester Memory Service, START, START: STrAtegies for RelaTives, State of the Nation Report: Dementia Care and Support in England (2013), Staying Independent, Stem Cell Research Centre, Stigma of Dementia, STrAtegies for RelaTives, Support for Carers, Sustainable Care, Sustainable Health and Care Services, Tackling Barriers to Innovation, Triangle of Care for Dementia, Trinity Homecare, UK Black Asian and Minority Ethnic Communities, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, World Dementia Council, World Dementia Envoy
|
Leave a comment
Second Global Dementia Legacy Event: Ottawa, September 11th/12th 2014 (Department of Health / Dementia Challenge / World Dementia Council / CIHR / AVIESAN)
Summary Canada and France are co-hosting the second Global Action Against Dementia Legacy Event in Ottawa (Canada) on September 11th – 12th 2014. This event will explore how to take advantage of partnership working and collaboration between industry and academia, … Continue reading →
Posted in Acute Hospitals, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Universal Interest
|
Tagged Academia-Industry Partnerships, Academia-Industry Synergies, Academic-Industry Collaborations, Alain Beaudet: President of Canadian Institutes of Health Research (CIHR), Alice Wong: Minister of State (Seniors) in Canada, Alzheimer Society of Canada, AVIESAN: French National Alliance for Life Sciences and Health, •Alzheimer Society of Canada, Big Data, Biotechnology, Canada, Canada's Research Strategy for Alzheimer's Disease, Canada-France Legacy Event, Canadian Institutes of Health Research (CIHR), Challenge on Dementia, Challenge on Dementia (David Cameron), Collaboration, Collaborative Projects, Cross-Sector Partnerships, Dementia Challenge, Dementia in Canada, Dementia Innovation, Dementia Research, Dementia Time-Bomb, Dennis Gillings: Former World Dementia Envoy, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies for Dementia, Drug Development for Alzheimer's Disease, Drug Discovery Programme, Drug Identification, Drug-Development Pipeline, Faye Forbes (Living With Dementia), France, Free Open Access Journals, G7 Global Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Agreements, G8 Summit on Dementia Communique, G8 Summit on Dementia Declaration, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Dementia Legacy Event on Academia-Industry Synergies, Global Leadership, Global Outlook, Incentives and Investment, Incentives for Drug Development, Innovation, Innovative Medicines Initiative, Institute of Health and Medical Research (Inserm), International Collaborations, International Programmes, Japan Legacy Event, Knowledge Networks, Knowledge Translation, Massachusetts Biotech Cluster: CONNECT, Matthew Dineen (Carer), Medical Devices, Networks, Networks and Alliances, Neurological Research, OECD Big Data and Sustainability Initiative for Large-Scale Research on Dementia, Open Access, Open Access Databases, Open Access Journals, Open Access Knowledge Resources, Open Access Research, Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Pharmaceutical Industry, Pharmacological Research, Philippe Zeller: Ambassador of France to Canada, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Regulatory Barriers: Regulatory Environment, Removing Regulatory Barriers, Research and Innovation, Research Networks, Resource and Incentives, Second Global Dementia Legacy Event, Second Global Dementia Legacy Event (Ottawa: September 2014), The Honourable Rona Ambrose: Minister of Health (Canada), UK Legacy Event, USA Legacy Event, Venture Capital (Approach to Research), World Dementia Council, Yves Lévy: French National Institute of Health and Medical Research (Inserm) and Chairman of Aviesan (French National Alliance for Life Sciences and Health Care)
|
Leave a comment
Google’s “Moonshot Project” on Tackling Ageing (Financial Times / Reuters / BBC News / ICO / Health and Technology)
Summary Arthur Levinson, formerly of Genentech, has left Roche to avoid any potential conflict of interest in his role as chief executive of Google’s Calico start-up company. Calico recently agreed a $1.5bn alliance with AbbVie, a rival of Roche, to develop treatments for … Continue reading →
Posted in Assistive Technology, In the News, International, Management of Condition, Non-Pharmacological Treatments, Parkinson's Disease, Pharmacological Treatments, Quick Insights, Universal Interest
|
Tagged 23andMe, AbbVie, Acute Kidney Injury (AKI), Age and Ageing, Age-Related Disease Research, Age-Related Neurodegenerative and Neurovascular Diseases, Ageing and Dementia, Ageing and Society, Ageing Population, Ageing Well, Arthur Levinson, Attitudes to Ageing, Basline Study: Collection of Anonymous Genetic and Molecular Information, BBC Health News, Big Data, Big Pharma, Compensation for Shaky Hands (Assistive Technology), Data Protection Act (1998), Data Protection Procurement Rules and Competition Rules (Potential Barriers to Information Sharing), Data Protection Procurement Rules and Competition Rules (Potential Barriers to Partnership Working), Data Sharing, Data Sharing Agreement, Data Sharing for Better Health, Diffusion of Innovation, Disease-Detecting Nanoparticles, Economist (Journal), Elizabeth Denham, Elizabeth Denham: Information Commissioner, Encouraging Innovation, Essential Tremor, Faculty of Law and Computer Laboratory: University of Cambridge, Financial Times, FT.com, Genentech, Google, Google Ageing-Related Ambitions, Google Basline Study: Anonymous Genetic and Molecular Information, Google Health-Related Ambitions, Google Moonshot Projects, Google Moonshot Projects: Ageing-Related, Google X, Google X: Cutting-Edge Technology Projects, Google X: Potentially Revolutionary Innovation, Google's DeepMind, Google's Research Division: Google X, Google's Social Network: Google+, Google’s Calico, Google’s DeepMind and Royal Free Trust Data-Sharing Agreement, Google’s Health Portfolio, Health and Technology (Journal), Health Technology, Healthy Life Expectancy, Human Longevity, Information Commissioner’s Office (ICO), Information Commissioner’s Website, International Collaborations, International Dementia Research Inventories, International Programmes, International Research, Lift Labs, Longevity, Open Access Databases, Open Access Knowledge Resources, Open Access Research, Open Data and Big Data, Open Science, Open Source Solutions, Partnership and Collaboration, Partnership Working, Pharmaceutical Industry, Pharmacological Research, Policies on Ageing, Preventative Care, Proactive Care, Reinventing Ageing, Research and Innovation, Reuters, Roche, Royal Free Hospital (London), Royal Free London NHS Trust, Royal Free NHS Foundation Trust, Science of Ageing, Smart Contact Lenses, Stabilization Technology: Tremor Cancellation, Streams app (Google’s DeepMind), Supporting Healthy Lifestyles, Tremor, Tremor and Other Hyperkinetic Movements, Tremor Cancellation Spoon (Stabilization Technology), Tremor-Cancelling Devices
|
Leave a comment
Second World Dementia Council Meeting Communique (Department of Health / Dementia Challenge / World Dementia Council)
Summary The World Dementia Council (WDC) has announced further steps to speed-up dementia research and increase investment, explaining plans agreed at a second meeting at the Organisation for Economic Cooperation and Development in Paris during July 2014. The four main … Continue reading →
Posted in Acute Hospitals, Charitable Bodies, Commissioning, Community Care, Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Integrated Care, International, Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest, World Health Organization (WHO)
|
Tagged Academia-Industry Partnerships, Alzheimer's Association, Behavioural Risk Factors, Bermuda Principles (Genomics), Blackfriars Consensus Statement, Challenge on Dementia (David Cameron), Charitable Funding, Collaborative Projects, Cross-Sector Partnerships, Daisy Acosta: World Dementia Council Member, Data Sharing, Dementia Challenge, Dementia Risk Factors, Department of Health Dementia Challenge, Epidemiology, European Commission, Financial Incentives, France / Canada Legacy Event, Free Open Access Journals, G20 Countries, G7 Countries, Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Harry Johns: President and CEO of Alzheimer’s Association, Harry Johns: World Dementia Council Member, Incentives and Investment, Incentives for Drug Development, Integrated Development Pathway, International Collaborations, International Dementia Research Inventories, International Programmes, Japan Legacy Event, Joel Menard: World Dementia Council Member, JP Morgan, Meera Pattabiraman: World Dementia Council Member, Modifiable Risk Factors, Ms. Cathrin Petty: JP Morgan, OECD, Open Access Databases, Open Access Journals, Open Access Knowledge Resources, Open Access Research, Open Science, Open Source Solutions, Organisation for Economic Co-operation and Development (OECD), Organisation for Economic Cooperation and Development, Partnership and Collaboration, Partnership Working, Philanthropic Funding, Philippe Amouyel: World Dementia Council Member, Prime Minister's Challenge on Dementia, Prime Minister’s Dementia Challenge, Professor Philippe Amouyel: EU Joint Programme on Neurodegenerative Disease Research, Public Health, Public-Private Partnership (PPP), Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Resource and Incentives, Risk Factors, Risk Factors for Alzheimer's Diseease, Second World Dementia Council Meeting Communique, Unhealthy Behaviours, Unhealthy Lifestyles, Unhealthy Living, WDC: World Dementia Council, World Dementia Council
|
1 Comment
NICE Supports NHS Free Trial Access to Medical Research in Journals and Ebooks (NICE)
Summary NHS staff working in England, Scotland, Wales and Northern Ireland have (for a trial period) free access to articles containing current information about research and best practice published in a massive range of medical and scientific journals. This development follows recommendations in the government-commissioned … Continue reading →
Posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), National, NHS, Northern Ireland, Scotland, UK, Wales
|
Tagged AAAS, Alzheimer's Research, Annual Reviews, Brain Research, Building Research Capacity, Community Research, Dame Janet Finch CBE, Dementia Research, Developing Research Skills, Elsevier, Finch Report: Accessibility Sustainability Excellence, Finch Report: Report of the Working Group on Expanding Access to Published Research Findings, Free Open Access Ebooks, Free Open Access Journals, Genetic Research, Institute of Physics, IOP Publishing, Joint Information Systems Committee (Jisc), Medical Research, Medical Research Council (MRC), National Institute for Health and Care Excellence (NICE), Nature Publishing Group, Neurodegenerative Disease Research, Neurological Research, NHS Education for Scotland, NHS Evidence: A-Z Journals List, NICE, Open Access Ebooks, Open Access Journals, Open Access Research, Oxford University Press, Pharmacological Research, Public Health Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Into Aging, Researcher Access to Data, Resources for Researchers, Royal Society of Chemistry, Springer, Working Group on Expanding Access to Published Research Findings
|
Leave a comment
